General Information of the Compound
| Compound ID |
CP0472713
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[4-([2.2]Paracyclophan-4-yl)-4-hydroxypiperidin-1-yl]-1-([2.2]-paracyclophan-4-yl)butan-1-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C41H45NO2
|
||||||||||||||||||
| Molecular Weight |
583.816
|
||||||||||||||||||
| Canonical SMILES |
OC1(CCN(CCCC(=O)c2cc3CCc4ccc(CCc2cc3)cc4)CC1)c1cc2CCc3ccc(CCc1cc2)cc3
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C41H45NO2/c43-40(38-28-34-13-11-30-3-7-32(8-4-30)15-19-36(38)20-17-34)2-1-25-42-26-23-41(44,24-27-42)39-29-35-14-12-31-5-9-33(10-6-31)16-21-37(39)22-18-35/h3-10,17-18,20,22,28-29,44H,1-2,11-16,19,21,23-27H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
IJSPBXBGZJAXBL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor